Ambroxol ratiopharm
Ambroxol ratiopharm thins and loosens mucus in the airways, making it easier to cough up.
Form
poretabletti
Strength
60 mg
Active Ingredient
Ambroxol hydrochloride
Manufacturer
Teva B.V.
How to Use
Dosage
For the first 2-3 days, take half an effervescent tablet three times a day. After that, take half an effervescent tablet twice a day.
Method
Dissolve half an effervescent tablet in a glass of water and drink it. You can take it with or without food.
Important
The maximum daily dose is one effervescent tablet twice a day (120 mg ambroxol hydrochloride per day).
Possible Side Effects
COMMON
- •Changes in taste
- •Numbness in the mouth or throat
- •Nausea
RARE
- •Vomiting
- •Dry mouth
- •Diarrhoea
- •Indigestion
- •Stomach pain
- •Fever
- •Oral hypersensitivity (mucosal reactions in the mouth)
- •Hypersensitivity reactions
- •Rash, hives
- •Dry throat
- •Excessive salivation
- •Shortness of breath (a sign of hypersensitivity)
- •Severe allergic reactions, including sudden swelling of the face or throat, difficulty breathing, dizziness, fast heartbeat, sweating, or fainting.
- •Severe skin reactions, such as widespread rash, red spots, skin peeling, or blisters that may include symptoms like fever and flu-like symptoms.
Important Warnings
- Do not use if you are allergic to ambroxol or any other ingredients in this medicine.
- Talk to your doctor or pharmacist if you have or have had liver or kidney disease.
- Stop taking this medicine and contact a doctor immediately if you develop a rash, including sores in your mouth, throat, nose, eyes, or genital area.
- This medicine is not suitable for children under 12 years old due to the high amount of active ingredient.
- Do not take cough suppressants at the same time as this medicine, as it can lead to a dangerous buildup of mucus in the airways.
Show 3 more warnings
- Do not use this medicine during pregnancy, especially during the first three months.
- Not recommended for breastfeeding mothers.
- Contact your doctor if your symptoms do not improve or worsen after 5 days.
Use in Elderly Patients
Category B
Current evidence on or experience with use in older adults is inconclusive or the medicine is insufficiently effective in the older adults. (updated 16.12.2024)